Peanut allergy therapy trial ‘sends half of kids into remission’
About half of children in a preliminary trial of a new regimen moved beyond desensitisation and could stop their therapy
Rapid escalation of oral immunotherapy can conquer peanut allergy to the point where children can eat peanuts as frequently as they like up to a year post-treatment, Australian researchers have shown.
Researchers led by Melbourne’s Murdoch Children’s Research Institute have reported their success in inducing remission of peanut allergy in a randomised controlled trial testing oral immunotherapy, alone or with a probiotic, against placebo.
